Indiana University Health University Hospital is a teaching hospital in Indianapolis, Indiana, United States, affiliated with the Indiana University School of Medicine and Indiana University Health.

During the past decade, Indiana University Health UH 1634 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Indiana University Health UH 1634" are "Diabetic Gastroparesis" (2 trials). Many other conditions were trialed in "Indiana University Health UH 1634" in a lesser frequency.

Most popular intervention types in "Indiana University Health UH 1634" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Metoclopramide Nasal Spray" (2 trials) and "Placebo Nasal Spray" (2 trials). Other intervention names were less common.

The vast majority of trials in "Indiana University Health UH 1634" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Indiana University Health UH 1634". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Indiana University Health UH 1634, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Indiana University Health UH 1634, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".